• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用线性回归元建模从概率敏感性分析计算部分样本信息的期望值。

Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

作者信息

Jalal Hawre, Goldhaber-Fiebert Jeremy D, Kuntz Karen M

机构信息

Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, California (HJ)

Center for Health Policy/Center for Primary Care & Outcomes Research, School of Medicine, Stanford University, Stanford, California (HJ, JDGF)

出版信息

Med Decis Making. 2015 Jul;35(5):584-95. doi: 10.1177/0272989X15578125. Epub 2015 Apr 3.

DOI:10.1177/0272989X15578125
PMID:25840900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4978941/
Abstract

Decision makers often desire both guidance on the most cost-effective interventions given current knowledge and also the value of collecting additional information to improve the decisions made (i.e., from value of information [VOI] analysis). Unfortunately, VOI analysis remains underused due to the conceptual, mathematical, and computational challenges of implementing Bayesian decision-theoretic approaches in models of sufficient complexity for real-world decision making. In this study, we propose a novel practical approach for conducting VOI analysis using a combination of probabilistic sensitivity analysis, linear regression metamodeling, and unit normal loss integral function--a parametric approach to VOI analysis. We adopt a linear approximation and leverage a fundamental assumption of VOI analysis, which requires that all sources of prior uncertainties be accurately specified. We provide examples of the approach and show that the assumptions we make do not induce substantial bias but greatly reduce the computational time needed to perform VOI analysis. Our approach avoids the need to analytically solve or approximate joint Bayesian updating, requires only one set of probabilistic sensitivity analysis simulations, and can be applied in models with correlated input parameters.

摘要

决策者通常既希望根据当前知识获得关于最具成本效益干预措施的指导,也希望了解收集更多信息以改善决策的价值(即通过信息价值[VOI]分析)。不幸的是,由于在足够复杂的模型中实施贝叶斯决策理论方法以用于现实世界决策时面临概念、数学和计算方面的挑战,VOI分析仍然未得到充分利用。在本研究中,我们提出了一种新颖的实用方法,通过结合概率敏感性分析、线性回归元建模和单位正态损失积分函数(一种VOI分析的参数方法)来进行VOI分析。我们采用线性近似并利用VOI分析的一个基本假设,即要求准确指定所有先验不确定性的来源。我们提供了该方法的示例,并表明我们所做的假设不会导致实质性偏差,但能大大减少执行VOI分析所需的计算时间。我们的方法避免了对联合贝叶斯更新进行解析求解或近似的需要,只需要一组概率敏感性分析模拟,并且可以应用于具有相关输入参数的模型。

相似文献

1
Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.使用线性回归元建模从概率敏感性分析计算部分样本信息的期望值。
Med Decis Making. 2015 Jul;35(5):584-95. doi: 10.1177/0272989X15578125. Epub 2015 Apr 3.
2
A Gaussian Approximation Approach for Value of Information Analysis.信息价值分析的高斯逼近方法。
Med Decis Making. 2018 Feb;38(2):174-188. doi: 10.1177/0272989X17715627. Epub 2017 Jul 22.
3
Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective.使用非参数回归方法的有效信息价值计算:应用视角
Value Health. 2016 Jun;19(4):505-9. doi: 10.1016/j.jval.2016.01.011. Epub 2016 Mar 30.
4
When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.多少证据才算足够?——运用系统决策分析和信息价值分析来确定是否需要更多证据。
Z Evid Fortbild Qual Gesundhwes. 2013;107(9-10):575-84. doi: 10.1016/j.zefq.2013.10.020. Epub 2013 Nov 12.
5
Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning-Based Metamodeling: A Case of Hepatitis C Treatment.使用基于机器学习的元建模进行成本效益和信息价值分析:以丙型肝炎治疗为例
Med Decis Making. 2023 Jan;43(1):68-77. doi: 10.1177/0272989X221125418. Epub 2022 Sep 16.
6
General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations.通用模拟生存数据的方法,用于计算样本信息的期望值。
Med Decis Making. 2023 Jul;43(5):595-609. doi: 10.1177/0272989X231162069. Epub 2023 Mar 27.
7
The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.决策者的约束条件对信息价值分析结果的影响
Value Health. 2018 Feb;21(2):203-209. doi: 10.1016/j.jval.2017.04.011. Epub 2017 May 31.
8
Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients.为膝关节置换患者制定抗生素预防指南的优先研究事项。
JDR Clin Trans Res. 2022 Jul;7(3):298-306. doi: 10.1177/23800844211020272. Epub 2021 Jun 17.
9
A systematic and critical review of the evolving methods and applications of value of information in academia and practice.系统而批判性地回顾了价值信息在学术界和实践中的不断发展的方法和应用。
Pharmacoeconomics. 2013 Jan;31(1):25-48. doi: 10.1007/s40273-012-0008-3.
10
The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.最佳样本量曲线(COSS):从信息价值分析中得出的最佳样本量的图形表示。
Pharmacoeconomics. 2019 Jul;37(7):871-877. doi: 10.1007/s40273-019-00770-z.

引用本文的文献

1
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study.孕早期详细异常超声筛查的临床效果及成本效益:一项混合方法研究
Health Technol Assess. 2025 May;29(22):1-250. doi: 10.3310/NLTP7102.
2
Microsimulation Estimates of Decision Uncertainty and Value of Information Are Biased but Consistent.决策不确定性和信息价值的微观模拟估计存在偏差但具有一致性。
Med Decis Making. 2025 Feb;45(2):127-142. doi: 10.1177/0272989X241305414. Epub 2024 Dec 25.
3
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information.

本文引用的文献

1
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patients.信息价值方法是否已准备好进入黄金时代?一项针对非ST段抬高型心肌梗死患者替代治疗策略的应用。
Int J Technol Assess Health Care. 2013 Oct;29(4):435-42. doi: 10.1017/S0266462313000433.
2
Expected value of sample information for multi-arm cluster randomized trials with binary outcomes.多臂群组随机对照试验中二分类结局的样本信息期望值。
Med Decis Making. 2014 Apr;34(3):352-65. doi: 10.1177/0272989X13501229. Epub 2013 Oct 1.
3
Linear regression metamodeling as a tool to summarize and present simulation model results.
面对不确定性制定药物审批决策:累积证据与信息价值。
Med Decis Making. 2024 Jul;44(5):512-528. doi: 10.1177/0272989X241255047. Epub 2024 Jun 3.
4
Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.临床试验设计的信息价值:考虑所有相关对照的重要性。
Pharmacoeconomics. 2024 May;42(5):479-486. doi: 10.1007/s40273-024-01372-0. Epub 2024 Apr 7.
5
Closed-Form Solution of the Unit Normal Loss Integral in 2 Dimensions, with Application in Value-of-Information Analysis.二维单位法向损耗积分的闭式解及其在信息价值分析中的应用。
Med Decis Making. 2023 Jul;43(5):621-626. doi: 10.1177/0272989X231171166. Epub 2023 Jun 2.
6
Metamodeling for Policy Simulations with Multivariate Outcomes.多变量结果政策模拟的元模型化。
Med Decis Making. 2022 Oct;42(7):872-884. doi: 10.1177/0272989X221105079. Epub 2022 Jun 23.
7
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials.应对 COVID-19 的新兴疗法:更多临床试验信息的价值。
Value Health. 2022 Aug;25(8):1268-1280. doi: 10.1016/j.jval.2022.03.016. Epub 2022 Apr 28.
8
Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation.计算样本信息的期望值,同时调整不完善实施的影响。
Med Decis Making. 2022 Jul;42(5):626-636. doi: 10.1177/0272989X211073098. Epub 2022 Jan 16.
9
Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials.样本信息的期望价值指导群组序贯临床试验的设计。
Med Decis Making. 2022 May;42(4):461-473. doi: 10.1177/0272989X211045036. Epub 2021 Dec 3.
10
Personalization of Medical Treatment Decisions: Simplifying Complex Models while Maintaining Patient Health Outcomes.医疗决策的个性化:简化复杂模型,同时保持患者健康结果。
Med Decis Making. 2022 May;42(4):450-460. doi: 10.1177/0272989X211037921. Epub 2021 Aug 20.
线性回归模型作为一种总结和呈现模拟模型结果的工具。
Med Decis Making. 2013 Oct;33(7):880-90. doi: 10.1177/0272989X13492014. Epub 2013 Jun 27.
4
A systematic and critical review of the evolving methods and applications of value of information in academia and practice.系统而批判性地回顾了价值信息在学术界和实践中的不断发展的方法和应用。
Pharmacoeconomics. 2013 Jan;31(1):25-48. doi: 10.1007/s40273-012-0008-3.
5
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.模型参数估计和不确定性分析:ISPOR-SMDM 建模良好实践工作组第 6 工作组的报告。
Med Decis Making. 2012 Sep-Oct;32(5):722-32. doi: 10.1177/0272989X12458348.
6
Value of information and pricing new healthcare interventions.价值信息和新医疗干预措施的定价。
Pharmacoeconomics. 2012 Jun 1;30(6):447-59. doi: 10.2165/11592250-000000000-00000.
7
Accounting for between-study variation in incremental net benefit in value of information methodology.在价值信息方法中,对增量净收益的研究间变异性进行解释。
Health Econ. 2012 Oct;21(10):1183-95. doi: 10.1002/hec.1781. Epub 2011 Sep 1.
8
Health economics in drug development: efficient research to inform healthcare funding decisions.药物研发中的健康经济学:提高研究效率,为医疗保健资金决策提供信息。
Eur J Cancer. 2010 Oct;46(15):2674-80. doi: 10.1016/j.ejca.2010.06.122. Epub 2010 Jul 23.
9
Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.价值信息分析在经济随机对照试验中的应用:间歇性跛行的治疗。
Value Health. 2010 Mar-Apr;13(2):242-50. doi: 10.1111/j.1524-4733.2009.00656.x. Epub 2009 Oct 8.
10
Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.信息价值和实施价值:应用分析框架为转移性激素难治性前列腺癌的资源分配决策提供信息。
Value Health. 2009 Mar-Apr;12(2):315-24. doi: 10.1111/j.1524-4733.2008.00431.x. Epub 2008 Jul 24.